AKYLA/ Financials
MarketsScreenerFinancialsResearchChat
Equity / PHARMACEUTICAL PREPARATIONS
NeOnc Technologies Holdings, Inc. Common Stock
XNAS · usd
SIC 2834 · PHARMACEUTICAL PREPARATIONS
FIGI BBG01KPDB5X8
3.27▲ 0.32 (10.85%)
As of 2026-10-23
Price / Volume
Valuation
Market Cap
Enterprise Value
Trailing P/E
—
Price / Sales
—
EV / Revenue
—
EV / EBITDA
—
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
—
Diluted EPS (TTM)
EBITDA Margin
—
Net Debt
Trading Information
Previous Close
2.95
Day's Range
2.90 – 3.55
52-Week Range
2.50 – 12.00
Volume
379.0K
Avg Volume
179.9K
Share Statistics
Shares Outstanding
Employees
5
Exchange
XNAS
Listed
2025-03-26
Share count as of August 10, 2026

NeOnc Technologies Holdings, Inc. Common Stock (NTHI) Financial Statements

View
Income Statement
Detail
Standard
Period
Quarterly
Loading Income Statement…
Key questions about NeOnc Technologies Holdings, Inc. Common Stock (NTHI)
What is NeOnc Technologies Holdings, Inc. Common Stock's Market Cap?
NeOnc Technologies Holdings, Inc. Common Stock's Market Cap is $84.8M, based on as-reported figures from SEC (XBRL) filings.
What is NeOnc Technologies Holdings, Inc. Common Stock's Enterprise Value?
NeOnc Technologies Holdings, Inc. Common Stock's Enterprise Value is $83.2M, based on as-reported figures from SEC (XBRL) filings.
What is NeOnc Technologies Holdings, Inc. Common Stock's Revenue (TTM)?
NeOnc Technologies Holdings, Inc. Common Stock's Revenue (TTM) is $0.00, based on as-reported figures from SEC (XBRL) filings.
What is NeOnc Technologies Holdings, Inc. Common Stock's Net Income (TTM)?
NeOnc Technologies Holdings, Inc. Common Stock's Net Income (TTM) is -$47.2M, based on as-reported figures from SEC (XBRL) filings.
What is NeOnc Technologies Holdings, Inc. Common Stock's Diluted EPS (TTM)?
NeOnc Technologies Holdings, Inc. Common Stock's Diluted EPS (TTM) is -1.82, based on as-reported figures from SEC (XBRL) filings.
What is NeOnc Technologies Holdings, Inc. Common Stock's Net Debt?
NeOnc Technologies Holdings, Inc. Common Stock's Net Debt is -$1.7M, based on as-reported figures from SEC (XBRL) filings.
Akyla / Financials · NTHIAs-filed SEC (XBRL) data
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024
Operating Expenses:
Research and Development Expense
Legal and professional
Selling, General and Administrative Expense
Stock-based compensation expense
Advisory fees——
Total Operating Expenses
Loss From Operations
Other Income (Expense):
Interest Income
Other Income——
Amortization of debt issuance costs———
Interest expense
Non-Operating Income (Expense)———
Loss on change in fair value of derivative liability related to Series A preferred stock———
Net Loss
Earnings Per Share (Basic)
Earnings Per Share (Diluted)